Migration patterns of avian embryonic bone marrow cells and their differentiation to functional T and B cells.

W. Weber,R. Mausner

DOI: https://doi.org/10.1007/978-1-4613-4169-7_5

Advances in experimental medicine and biology

Abstract:

What problem does this paper attempt to address?

Mechanisms of Raynaud's disease

John P Cooke,Janice M Marshall

DOI: https://doi.org/10.1191/1358863x05vm639ra

Abstract:Raynaud's phenomenon is due to transient cessation of blood flow to the digits of the hands or feet. An attack of Raynaud's phenomenon is classically manifested as triphasic color changes. The white phase is due to excessive vasoconstriction and cessation of regional blood flow. This phase is followed by a cyanotic phase, as the residual blood in the finger desaturates. The red phase is due to hyperemia as the attack subsides and blood flow is restored. An attack is frequently associated with pain and/or paresthesia due to sensory nerve ischemia. Variants of Raynaud's phenomenon include acrocyanosis and primary livedo reticularis, each of which is associated with reduced skin blood flow, exacerbated by cold or emotional upset. Raynaud's phenomenon in the absence of other disorders is primary Raynaud's phenomenon, or Raynaud's disease. The mechanisms of Raynaud's disease include increased activation of the sympathetic nerves, in response to cold or emotion; an impaired habituation of the cardiovascular response to stress may contribute. In addition, there appears to be a local fault, which is likely multifactorial. This local fault is due to an alteration in vascular function rather than vascular structure. The alteration in vascular function may be related to increased sensitivity to cold of the adrenergic receptors on the digital artery vascular smooth muscle. In some cases, locally released or systemically circulating vasoconstrictors may participate, including endothelin, 5-hydroxytryptamine and thromboxane. A deficiency or increased degradation of nitric oxide, possibly due to increased oxidative stress, may be involved in some cases. These recent pathophysiological insights may lead to new therapeutic options.
Cold Hands or Feet: Is It Raynaud's or Not?

Daniella Kadian-Dodov

DOI: https://doi.org/10.1016/j.mcna.2023.04.005

Abstract:Raynaud's phenomenon is an exaggerated response to cold stimuli that may be primary or secondary. The diagnosis relies on patient history and physical examination to distinguish RP from other vasomotor dysfunction (e.g. acrocyanosis, pernio, small fiber neuropathy with vasomotor symptoms, and complex regional pain syndrome). Achenbach syndrome, or spontaneous venous hemorrhage, may also be mistaken for RP but is a self-limiting phenomenon. Laboratory evaluation and vascular diagnostic testing may identify SRP causes. Regardless of etiology, treatment includes warming with trigger avoidance, and consideration of vasodilators (eg. calcium channel, alpha-1 blockers). SRP with digital ulceration may require PDE5i, endothelin-1 receptor blockers, and prostanoids. Refractory cases may require pneumatic arterial pumps, botulinum toxin administration, or surgical sympathectomy.
Kaposiform Hemangioendothelioma Presented with Raynaud Phenomenon: a Case Report

Lingke Liu,Weizhong Gu,Liping Teng,Yiping Xu,Fei Zheng,Minfei Hu,Meiping Lu,Xuefeng Xu

DOI: https://doi.org/10.1186/s12887-023-04407-1

2023-01-01

BMC Pediatrics

Abstract:Background Kaposiform hemangioendothelioma (KHE) is a rare vascular neoplasm affecting infants or young children. KHE includes a spectrum of lesions, ranging from small and superficial tumors to large and invasive lesions with Kasabach-Merritt phenomenon (KMP). Currently, no published studies have reported a KHE presenting as thrombocytopenia and Raynaud phenomenon. Case presentation A 2-year-old boy with right hand swelling and thrombocytopenia was admitted to our hospital. His right hand turned swelling and red, even occasionally cyanotic. This condition became worse in response to cool environments and improved with warming, and platelet counts were between 50 ~ 80 × 10^9/L. Physical examination on admission revealed the swelling and frostbite-like rash of the right-hand fingers, and the skin temperature of the right hand was lower than the left. On day 3 of admission, chest CT results showed an irregular mass on the right side of the spine. The puncture biopsy demonstrated positive CD31, D2-40, and FLI1 immunohistochemical staining, but negative GLUT1 staining, confirming the diagnosis of KHE. Furthermore, endothelin-1 (ET1) expression levels significantly increased, and eNOS and A20 expression levels significantly decreased comparing with control patients. The patient received methylprednisolone and sirolimus treatments, and his condition gradually improved during the follow-up. Conclusions We reported the first case of KHE presenting with thrombocytopenia and Raynaud phenomenon. The development of Raynaud phenomenon could be associated with increased ET-1 and reduced eNOS and A20 expressions. Careful differential diagnosis of hidden KHE should be considered in children with thrombocytopenia and Raynaud phenomenon.
Raynaud's phenomenon associated with psoriatic arthritis

Mohd Jazman Che Rahim,Jo Anne Lim,Wan Syamimee Wan Ghazali

DOI: https://doi.org/10.1136/bcr-2023-258215

2024-03-05

Abstract:We report a case of Raynaud's phenomenon in a patient with psoriatic arthritis (PsA). A middle-aged right-handed housewife presented with complaints of severely painful hand discolouration for 1 week, which usually worsened with cold exposure. She was diagnosed with PsA 6 months earlier. Her PsA was well controlled with weekly methotrexate. Physical examination showed no features of scleroderma or skin necrosis of her right hand. Both radial pulses were strong and symmetrical. Her nailfolds were visibly normal. The extractable nuclear antigen panel and other blood investigations were negative for scleroderma and other possible causes of secondary Raynaud's phenomenon. Occupational or environmental factors were also excluded. Dermatoscope examination of the nailfolds revealed some areas of dilated capillary loops, areas of vascular sparing and proximal nail fold telangiectasia. The diagnosis of secondary Raynaud's phenomenon was made, and an oral calcium channel blocker was started. The patient had significant improvement in symptoms shortly afterwards.
Efficacy analysis of minimally invasive surgery for Raynaud's syndrome

Fengwei Yu,Yongtao Liu,Chengnian Zhang,Botao Pang,Daijie Zhang,Wei Zhao,Xuecheng Li,Weiqiang Yang

DOI: https://doi.org/10.1186/s12893-023-02225-x

2023-10-14

Abstract:Background: Raynaud's syndrome (RS), also referred to as Raynaud's phenomenon, is a vasospastic disorder causing episodic color changes in extremities upon exposure to cold or stress. These manifestations, either primary Raynaud's phenomenon (PRP) or associated with connective tissue diseases like systemic sclerosis (SSc) as secondary Raynaud's phenomenon (SRP), affect the quality of life. Current treatments range from calcium channel blockers to innovative surgical interventions, with evolving efficacy and safety profiles. Methods: In this retrospective study, patients diagnosed with RS were selected based on complete medical records, ensuring homogeneity between groups. Surgeries involved microscopic excision of sympathetic nerve fibers and stripping of the digital artery's adventitia. Postoperative care included antibiotics, analgesia, oral nifedipine, and heat therapies. Evaluation metrics such as the VAS pain score and RCS score were collected bi-weekly. Data analysis was conducted using SPSS 26.0, with significance set at p < 0.05. Results: In total, 15 patients formed the experimental group, with five presenting fingertip soft tissue necrosis and ten showing RS symptoms. Comparative analysis of demographic data between experimental and control groups, both containing 15 participants, demonstrated no significant age and gender difference. However, the "Mean Duration of RP attack" in the experimental group was notably shorter (9.47 min ± 0.31) than the control group (19.33 min ± 1.79). The RS Severity Score also indicated milder severity for the experimental cohort (score: 8.55) compared to the control (score: 11.23). Postoperative assessments at 2, 4, and 6 weeks revealed improved VAS pain scores, RCS scores, and other measures for the experimental group, showing significant differences (p < 0.05). One distinctive case showcased a variation in the common digital nerve and artery course in an RS patient. Conclusion: Our retrospective analysis on RS patients indicates that microsurgical techniques are safe and effective in the short term. As surgical practices lean towards minimally invasive methods, our data supports this shift. However, extensive, prospective studies are essential for conclusive insights.
Psychological factors in symptom severity and quality of life in Raynaud's phenomenon

Dulcie Irving,Jo Daniels

DOI: https://doi.org/10.1017/s1352465823000620

2024-01-30

Behavioural and Cognitive Psychotherapy

Abstract:Background: Despite emotional stress being recognised as a key trigger for Raynaud's phenomenon episodes, research in the area is still in its infancy. Aims: This study investigated the role of psychological factors relating to symptom severity and quality of life, and differences between Raynaud's types (primary and secondary) to further inform the development of intervention in this field. Method: A cross-sectional design was used. Two hundred and ten adults with Raynaud's completed an online questionnaire measuring stress, anxiety, depression, anxiety sensitivity, beliefs about emotions, symptom severity and quality of life. Results: Primary and secondary Raynaud's groups differed in anxiety (p < .004), symptom severity (p < .001) and quality of life (p < .001). Stepwise multiple regressions indicated anxiety and Raynaud's type explained 23% variance in hand symptom severity (p < .001); anxiety, Raynaud's type and anxiety sensitivity explained 29% variance in symptom severity (global impact, p < .001); depression, Raynaud's type and anxiety sensitivity explained 32% variance in quality of life (p < .001). Conclusions: Results highlight the importance of psychological factors in Raynaud's phenomenon, indicating possible targets for treatment. Interventions such as cognitive behavioural therapy, which target both physical and psychological wellbeing, bear some promise as an adjuvant therapy for this group.

psychology, clinical
Etiology and Clinical Characteristics of Primary Epistaxis.

Hai-Yan Li,Ting Luo,Liang Li,Ying Liu,Xiang Zhai,Xu-Dong Wang

DOI: https://doi.org/10.21037/atm-22-6590

IF: 3.616

2023-01-01

Annals of Translational Medicine

Abstract:Background:Primary epistaxis (rupture of nasal artery vessels) is a common emergency, but the related factors are still controversial. This study collected the data on primary epistaxis patients and healthy people undergoing a physical examination at the same center to explore and classify primary epistaxis by its characteristics.Methods:Primary epistaxis was divided into septal epistaxis and non-septal epistaxis, and logistic regression was performed to determine the risk factors.Results:In total, 196 cases of septal epistaxis and 127 cases of non-septal epistaxis, and the control group was 182 healthy subjects. There were significant differences in sex, drinking history, hypertension history and hyperlipidemia between the bleeding group and the control group, but no correlation with smoking, diabetes, cardiovascular and cerebrovascular events, or anticoagulant drug use. In the age group of 26-40 years it was related to alcohol consumption and hypertension, for those aged 41-55 years it was related to hypertension, in the age group of 56-70 years it was related to hypertension, high triglyceride and high apolipoprotein B levels, and no related factors were found in the age group >70 years. The risk factors for non-septal cases were increased low-density lipoprotein (LDL) [P=0.035; odds ratio (OR), 2.450; 95% confidence interval (CI): 1.067-5.624], male sex (P=0.002; OR, 3.136; 95% CI: 1.501-6.554), and younger age (P=0.000; OR, 0.941; 95%CI: 0.920-0.962). All patients with nosebleed underwent nasal endoscopy and the bleeding site was successfully located and treated with electrocoagulation. No further bleeding or serious complications occurred after 6 months of follow-up.Conclusions:Primary epistaxis is more common in males and is related to alcohol consumption, hypertension, and hyperlipidemia. In the young age groups, male sex, and increased LDL were high risk factors for non-septal hemorrhage in winter and spring. Nasal endoscopy and electrocoagulation are safe and effective.
Calcium channel blockers for primary Raynaud's phenomenon

Holly Ennis,Michael Hughes,Marina E Anderson,Jack Wilkinson,Ariane L Herrick

DOI: https://doi.org/10.1002/14651858.CD002069.pub5

2016-02-25

Abstract:Background: Calcium channel blockers are the most commonly prescribed drugs for people with primary Raynaud's phenomenon. Primary Raynaud's phenomenon is a common condition characterised by an exaggerated vasospastic response to cold or emotion: classically the digits (fingers and toes) turn white, then blue, then red. This is an update of the review first published in 2014. Objectives: To assess the effects of different calcium channel blockers for primary Raynaud's phenomenon as determined by attack rates, severity scores, participant-preference scores and physiological measurements. Search methods: For this update the Cochrane Vascular Trial Search Co-ordinator searched the Specialised Register (last searched January 2016) and the Cochrane Register of Studies (CENTRAL) (2015, Issue 12). In addition the TSC searched clinical trials databases. Selection criteria: Randomised controlled trials evaluating the effects of oral calcium channel blockers for the treatment of primary Raynaud's phenomenon. Data collection and analysis: Three review authors independently assessed the trials for inclusion and their quality, and extracted the data. Data extraction included adverse events. We contacted trial authors for missing data. Main results: We included seven randomised trials with 296 participants. Four trials examined nifedipine and the remainder nicardipine. Comparisons were with placebo in six trials and with both dazoxiben and placebo in one trial (only the nifedipine versus placebo data were used within this review). Treatment with oral calcium channel blockers was minimally effective in primary Raynaud's phenomenon at decreasing the frequency of attacks (standardised mean difference of 0.23; 95% confidence interval (CI) 0.08 to 0.38, P = 0.003). This translates to 1.72 (95% CI 0.60 to 2.84) fewer attacks per week on calcium channel blockers compared to placebo. One trial provided details on duration of attacks reporting no statistically significant difference between the nicardipine and placebo groups (no P value reported). Only two trials provided any detail of statistical comparisons of (unvalidated) severity scores between treatment groups: one of these trials (60 participants) reported a mean severity score of 1.55 on placebo and 1.36 on nicardipine, difference 0.2 (95% CI of difference 0 to 0.4, no P value reported) and the other trial (three participants only with primary Raynaud's phenomenon) reported a median severity score of 2 on both nicardipine and placebo treatment (P > 0.999) suggesting little effect on severity. Participant-preference scores were included in four trials, but in only two were results specific to participants with primary Raynaud's phenomenon, and scoring systems differed between trials: scores differed between treatments in only one trial, in which 33% of participants on placebo and 73% on nifedipine reported improvement in symptoms (P < 0.001). Physiological measurements were included as outcome measures in five trials (different methodologies were used in each): none of these trials found any statistically significant between-treatment group differences. Treatment with calcium channel blockers appeared to be associated with a number of adverse reactions, including headaches, flushing and oedema (swelling). Overall, the trials were classed as being at low or unclear risk of bias; and the quality of the evidence presented was moderate for number of attacks, very low for duration of attacks, high for severity scores and low for patient preference scores. Authors' conclusions: The randomised controlled trials included in this review provide moderate quality evidence that oral calcium channel blockers are minimally effective in the treatment of primary Raynaud's phenomenon as measured by the frequency of attacks and high-quality evidence that they have little effect on severity. We are unable to comment on duration of attacks or on patient preference due to the very low and low quality of evidence as a result of small sample sizes in the included studies and the variable data quality of outcome measures.
Black Tongue: A Rare Presentation of Rhupus Syndrome

Piyush Puri,Princy Sardana,Ninia Goyal,Rajpreet S Arora,Akshit Chitkara

DOI: https://doi.org/10.7759/cureus.40240

2023-06-11

Cureus

Abstract:Black tongue is a benign condition typically caused by the overgrowth of dead skin cells, resulting in elongated papillae and a hairy appearance. Other factors contributing to this condition include inadequate oral hygiene, a soft diet, and staining from bacteria, food, yeast, and other substances. It may cause symptoms such as bad breath, a metallic taste in the mouth, and an unsightly black hairy-looking tongue. Here, we present a case of a 30-year-old female who came to our hospital complaining of bad breath and a black tongue for the past month. She had previously taken antibiotics at the primary care medical center, but there was no improvement. We then prescribed her fluconazole, an antifungal medication, for the next two weeks. After two weeks, she returned with a slightly improved tongue color. Further investigation revealed a history of abortion and mild intermittent joint pains, for which she had been self-medicating with over-the-counter acetaminophen. A complete work-up led to the discovery of positive anti-cyclic citrullinated peptide (anti-CCP) antibodies, anti-double-stranded (anti-DS) DNA antibodies, and ANA, leading to the diagnosis of Rhupus Syndrome, an overlap of systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA).
An inexpensive and effective device to manage nasal Raynaud’s and rosacea overlap symptoms

Chi Kit Yan,Vishal Madan

DOI: https://doi.org/10.1093/ced/llae265

2024-07-15

Clinical and Experimental Dermatology

Abstract:Raynaud’s phenomenon (RP) commonly leads to reduced circulation to digits, ears or nose. Nasal RP is a difficult condition to manage with medical treatments. This correspondence explored 2 cases of nasal RP being managed by a novel nasal warming device.

dermatology
Endoscopic thoracic sympathectomy for Raynaud Syndrome

Xiang Dai,Yanguo Liu,Jun Wang

DOI: https://doi.org/10.3760/cma.j.issn.1001-4497.2018.09.016

2018-01-01

Abstract:Raynaud Syndrome(RS) is a kind of paroxysmal digital ischemic disease whose typical symptom is characteristic tricolor change featuring pallor,cyanosis,and erythema induced by cold or emotion changing.The pathogenesis of RS is still not entirely clear,and there is no radical treatment.In recent years,endoscopic thoracic sympathectomy (ETS) for Raynaud Syndrome is gradually applied.ETS produces a high rate of initial relief,and has lower risk and technical difficulty compared with other surgical options,while its poor long-term outcome can't be ignored.There is currently a lack of a large number of clinical controlled trials between different operations,and there is still a need for further improved surgical procedures and accurate postoperative evaluation criteria.In this review,the recent advances of ETS is summarized.
The clinical relevance of Raynaud’s phenomenon symptom characteristics in systemic sclerosis

Hughes, Michael,Huang, Suiyuan,Pauling, John D,Sabbagh, Maya,Khanna, Dinesh

DOI: https://doi.org/10.1007/s10067-022-06206-y

2022-05-18

Clinical Rheumatology

Abstract:Raynaud’s phenomenon (RP) is a cardinal feature of systemic sclerosis (SSc) and manifests with pain, digital colour change, sensory symptoms, and impaired function. SSc-RP is exacerbated by cold exposure (RP ‘attacks’) but many patients report persistent symptoms of background digital ischaemia. The aim of our study was to examine the significance of RP with digital colour change with or without symptoms, and persistent colour change in between attacks. Patients with SSc responses were obtained from the Patient Survey of experiences of Raynaud’s Phenomenon (PASRAP). We enquired about symptoms associated with Raynaud’s attacks, and persistent symptoms in between attacks. Data were analysed as descriptive statistics with appropriate parametric/non-parametric testing. Relevant PASRAP survey question data from 747 evaluable SSc patients from across three continents were analysed. Isolated colour change was rare (29/484, 6%). Digital ulcers were more common in SSc-RP associated with other sensory symptoms (42.1% vs. 24.1%, P=0.057) and more readily treated with phosphodiesterase-type 5 inhibitors (22.5% vs. 10.3%%, P=0.124). Over one-third of patients (n=92/239, 38%) reported persistent colour change in between Raynaud’s attacks. Patients with persistent colour change were more likely to have pulmonary arterial hypertension (15.2% vs. 7.5%, P=0.057) and be treated with calcium channel blockers (54.3% vs. 39.0%, P=0.021). SSc-RP with colour change and other symptoms and/or or persistent decolourisation in between attacks were more likely to have vascular complications of SSc and be treated with vascular therapies. Future research should explore the judicious use of vascular therapies as a potential form of disease modification in SSc.

rheumatology
Scleroderma of the esophagus.

G. Brindley,E. Texter

Abstract:
[Experience in Treatment of Raynaud's Syndrome by Chemical Thoracic Sympathectomy].

Jun Zhao,Guo-xiang Dong,Jing-yuan Luan

DOI: https://doi.org/10.3760/j:issn:0376-2491.2003.22.005

2003-01-01

Abstract:OBJECTIVE:To summarize the experience in treatment of Raynaud's syndrome with chemical thoracic sympathectomy (CTS) guided by X ray.METHODS:From March 2001 to December 2002,35 cases (66 limbs) of Raynaud's syndrome were treated by CTS. Guided by X ray, a needle was punctured through the back skin to the second or third thoracic sympathetic ganglion beside the thoracic vertebrae and 2 ml of 5% phenol was injected.RESULTS:The first CTS treatment produced an excellent effect on 32 limbs, good effect on 12 limbs, and no effect on 22 limbs with an effective rate of 66.7% (44/66). The same treatment was performed on the limbs without effect 1 - 2 days after the first treatment and produce excellent effect on 2 limbs, good effect on 6 limbs, and no effect on 14 limbs with an effective rate of 36.4% (8/22). The efficiency rate of the first hospitalization was 78.8%. The effective rate of treating primary Raynaud's disease by CTS was 88.5% and that of treating secondary one was 42.8%. 85% of the patients were followed up for 9 months on average with an efficiency rate of 61%.CONCLUSION:CTS is mini-invasive, cheap, easy to popularize, and a relatively ideal choice in treatment of Raynaud's syndrome. Complications can be minimum only if the operation is performed carefully.
Mottled Raynaud's phenomenon and hand-arm vibration syndrome: followed up for 10 years

Harukazu Hirano

DOI: https://doi.org/10.1136/bcr-2023-257314

2024-01-16

Abstract:Vibration white finger is a form of secondary Raynaud's phenomenon (RP) caused by the use of handheld vibrating tools. RP usually appears on the extremities of the fingers, and its borders are well recognised. No reports have been published on 'mottled' RP in continuous observation from the onset to the disappearance of RP. A man in his 60s who had been using vibrating tools such as jackhammers and tampers for 30 years presented with sensations of coldness, burning and numbness. Whole-body cold exposure was performed outdoors in winter, and RP was photographed continuously. 'Mottled' RP can be defined as triphasic colour changes: white, blue and red. The patient was taken off work, kept warm and medicated. His symptoms improved slightly after 10 years of follow-up, but the RP did not disappear. 'Mottled' RP is rare and refractory and should be recognised as a form of RP.
Experience in Treatment of Raynaud's Syndrome by Chemical Sympathectomy:97 Cases

Jin Tao Han,Jun Zhao,Yong Guang Peng

DOI: https://doi.org/10.3321/j.issn:1671-167x.2008.03.015

2008-01-01

Abstract:OBJECTIVE:To summarize the curative effect in treatment of Raynaud's syndrome with chemical thoracic sympathectomy (CTS) guided by X-ray since 2001.METHODS:From March 2001 to August 2007, 97 patients with Raynaud's syndrome (186 limbs) were treated by CTS. Guided by X-ray, a needle was punctured through the back skin to the second thoracic sympathetic ganglion beside the thoracic vertebrae and 2 mL of 5% (v/v) phenol was injected.RESULTS:The first CTS treatment produced a good effect on 146 limbs with an effective rate of 78.5% (146/186). The same treatment was performed on the limbs with no effect 1-2 days after the first treatment and produced good effect on 13 limbs with an effective rate of 32.5% (13/40). The total effective rate of the patients who were hospitalized for the first time was 85.5% (159/186). Of the 97 patients, 78 patients (80.4%) were followed up for 47 months on an average with an effective rate of 69.5%. And the rate of complications was 11.4% for pheumothorax, and 3.9% for hydrothorax. Hyperalgesia on axillary region and anterior chest wall; Horner syndrome and sinus bradycardia were rare.CONCLUSION:CTS is minimally invasive and effective in treatment of Raynaud's syndrome.
Botulinum Toxin for the Treatment of Raynaud's Conditions of the Hand: Clinical Practice Updates and Future Directions

Patrick O'Donohoe,Jake McDonnell,Justin Wormald,Lylas Aljohmani,Kevin Cronin,Laura Durcan,Oran Kennedy,Roisin Dolan

DOI: https://doi.org/10.3390/toxins16110472

IF: 5.075

2024-11-02

Toxins

Abstract:Raynaud's conditions of the hand, referred to commonly as Raynaud's phenomenon, both primary and secondary, represents a spectrum of disorders affecting the digits, characterised by recurrent episodes of vasospasm that result in a triad of symptoms: pain, pallor, and cyanosis. Various therapies, ranging from conservative hand therapy techniques to surgical sympathectomy, have been explored with inconsistent results. Recently, the local administration of botulinum toxin type-A (BTX-A) has re-emerged as a treatment option for this condition. This review delves into the mechanistic pathways of BTX-A therapy, optimal dosing concentrations, administration techniques, and its safety profile. A critical analysis of published studies to date demonstrates varied clinical efficacy of BTX-A in Raynaud's conditions based on patient-reported outcome measures and objective measures of outcomes assessment. Thus, in order to accurately assess the clinical effectiveness of BTX-A in future robust studies, this review emphasises the importance of streamlining patient selection to minimise heterogeneity in disease severity, optimising recruitment to ensure adequate statistical power, and establishing sensitive outcome measures to monitor response and discern treatment efficacy. Additionally, addressing concerns such as minimising antibody resistance, extending the duration of treatment effects on tissues, and exploring new modalities to assess hand perfusion will be focal points for future research and BTX-A drug development.

toxicology,food science & technology
Capillaroscopic differences between primary Raynaud phenomenon and healthy controls indicate potential microangiopathic involvement in benign vasospasms

Sophie Brunner-Ziegler,Eva Dassler,Markus Müller,Marco Pratscher,Nikolaus Franz-Ferdinand Maria Forstner,Renate Koppensteiner,Oliver Schlager,Bernd Jilma

DOI: https://doi.org/10.1177/1358863x231223523

2024-02-10

Vascular Medicine

Abstract:Vascular Medicine, Ahead of Print. Background:For primary Raynaud phenomenon (PRP), an otherwise unexplained vasospastic disposition is assumed. To test the hypothesis of an additional involvement of distinct ultrastructural microvascular alterations, we compared the nailfold capillary pattern of patients with PRP and healthy controls.Methods:A total of 120 patients with PRP (with a median duration of vasospastic symptoms of 60 [IQR: 3–120] months) were compared against 125 controls. In both groups, nailfold capillaroscopy was performed to record the presence of dilatations, capillary edema, tortuous capillaries, ramifications, hemorrhages, and reduced capillary density and to determine a semiquantitative rating score. Further, the capacity of finger skin rewarming was investigated by performing infrared thermography in combination with cold provocation.Results:Unspecific morphologic alterations were found in both, PRP, such as controls, whereby the risk for PRP was four times as high in the presence of capillary dilations (CI: 2.3–7.6) and five times as high if capillary density was reduced (CI: 1.9–13.5). Capillary density correlated with thermoregulatory capacity in both hands in the PRP group, but not in controls. In addition, a negative correlation between the microangiopathy score and the percentage degree of rewarming in both hands was found for patients with PRP only.Conclusion:We found specific differences within the microvascular architecture between patients with PRP and controls. As a conclusion, PRP may not be an entirely benign vasospastic phenomenon, but might be associated with subtle microcirculatory vasculopathy. In addition, we suggest that the implementation of a scoring system might serve as guidance in the diagnostic process at least of patients with long-standing PRP.

peripheral vascular disease
Common tongue conditions in primary care

Brian V Reamy,Richard Derby,Christopher W Bunt

2010-03-01

Abstract:Although easily examined, abnormalities of the tongue can present a diagnostic and therapeutic dilemma for physicians. Recognition and diagnosis require a thorough history, including onset and duration, antecedent symptoms, and tobacco and alcohol use. Examination of tongue morphology and a careful assessment for lymphadenopathy are also important. Geographic tongue, fissured tongue, and hairy tongue are the most common tongue problems and do not require treatment. Median rhomboid glossitis is usually associated with a candidal infection and responds to topical antifungals. Atrophic glossitis is often linked to an underlying nutritional deficiency of iron, folic acid, vitamin B12, riboflavin, or niacin and resolves with correction of the underlying condition. Oral hairy leukoplakia, which can be a marker for underlying immunodeficiency, is caused by the Epstein-Barr virus and is treated with oral antivirals. Tongue growths usually require biopsy to differentiate benign lesions (e.g., granular cell tumors, fibromas, lymphoepithelial cysts) from premalignant leukoplakia or squamous cell carcinoma. Burning mouth syndrome often involves the tongue and has responded to treatment with alpha-lipoic acid, clonazepam, and cognitive behavior therapy in controlled trials. Several trials have also confirmed the effectiveness of surgical division of tongue-tie (ankyloglossia), in the context of optimizing the success of breastfeeding compared with education alone. Tongue lesions of unclear etiology may require biopsy or referral to an oral and maxillofacial surgeon, head and neck surgeon, or a dentist experienced in oral pathology.
The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study

Gabrielle Virgili-Gervais,Bianca Matthews,Elsa-Lynn Nassar,Marie-Eve Carrier,Linda Kwakkenbos,John D Pauling,Susan J Bartlett,Amy Gietzen,Karen Gottesman,Geneviève Guillot,Marie Hudson,Laura K Hummers,Amanda Lawrie-Jones,Vanessa L Malcarne,Maureen D Mayes,Michelle Richard,Maureen Sauvé,Robyn K Wojeck,Luc Mouthon,Andrea Benedetti,Brett D Thombs,Scleroderma Patient-centered Intervention Network investigators,Catherine Fortuné,Claire E Adams,Richard S Henry,Ghassan El-Baalbaki,Kim Fligelstone,Tracy Frech,Daphna Harel,Monique Hinchcliff,Sindhu R Johnson,Maggie Larche,Catarina Leite,Christelle Nguyen,Karen Nielsen,Janet Pope,François Rannou,Tatiana Sofía Rodriguez-Reyna,Anne A Shouffoer,Maria E Suarez-Almazor,Christian Agard,Laurent Alric,Marc André,Floryan Beaslay,Elana J Bernstein,Sabine Berthier,Lyne Bissonnette,Sophie Blaise,Eva Bories,Alessandra Bruns,Carlotta Cacciatore,Patricia Carreira,Marion Casadevall,Benjamin Chaigne,Lorinda Chung,Benjamin Crichi,Thylbert Deltombe,Christopher Denton,Tannvir Desroche,Robyn Domsic,James V Dunne,Bertrand Dunogue,Regina Fare,Dominique Farge-Bancel,Paul R Fortin,Loraine Gauzère,Anne Gerber,Jessica Gordon,Brigitte Granel-Rey,Aurélien Guffroy,Geneviève Gyger,Erica Hachulla,Sabrina Hoa,Michael Hughes,Alena Ikic,Nader Khalidi,Kimberly Lakin,Marc Lambert,David Launay,Yvonne C Lee,Paul Legendre,Hélène Maillard,Nancy Maltez,Joanne Manning,Isabelle Marie,Maria Martin Lopez,Thierry Martin,Ariel Masetto,Arsène Mekinian,Sheila Melchor Díaz,Morgane Mourguet,Mandana Nikpour,Louis Olgane,Vincent Poindron,Susanna Proudman,Grégory Pugnet,Loïc Raffray,Alexis Régent,Frederic Renou,Sébastien Rivière,David Robinson,Esther Rodríguez Almazar,Sophie Roux,Perrine Smets,Vincent Sobanski,Robert Spiera,Virginia Steen,Evelyn Sutton,Carter Thorne,Damien Vagner,John Varga,Pearce Wilcox,Mara Cañedo Ayala,Vanessa Cook,Cassidy Dal Santo,Tiffany Dal Santo,Monica D'Onofrio,Sophie Hu,Marieke Alexandra Neyer,Sabrina Provencher

DOI: https://doi.org/10.1016/S2665-9913(24)00189-9

Abstract:Background: Raynaud's phenomenon is the earliest and most common systemic sclerosis manifestation. Episodes can be triggered by cold exposure and ambient temperature changes. Small studies have found that Raynaud's phenomenon outcomes were associated with season. We aimed to map the degree that differences in ambient temperature are associated with Raynaud's phenomenon outcomes across the temperature spectrum. Methods: People with Raynaud's phenomenon secondary to systemic sclerosis in the Scleroderma Patient-centered Intervention Network Cohort completed past-week Raynaud's phenomenon severity assessments (0-10 numerical rating scale) at enrolment and longitudinally at 3-month intervals. Mean daily temperature and feels like temperature, which incorporates wind chill and humidity, for the week before each assessment were extracted for each participant from a weather site close to the participant's recruiting centre via the Iowa Environmental Mesonet. We used linear mixed models with basis splines to flexibly model non-linear changes in Raynaud's phenomenon severity across the temperature spectrum. People with lived experience of systemic sclerosis contributed to the study design and interpretation. Findings: Between April 15, 2014 and Aug 1, 2023, we included data on 20 233 Raynaud's phenomenon severity assessments from 2243 participants. 1964 (88%) of 2243 participants were women, 279 (12%) were men, and 1813 (82%) were White. Mean age was 54·8 (SD 12·7) years. The maximum predicted Raynaud's phenomenon severity score was 6·8 points (95% CI 5·6-8·1), which occurred at -25°C. Severity scores decreased minimally from -15°C to 5°C (0·05-0·21 points per 5°C difference), then decreased in larger steps between 5°C and 25°C (0·37-0·54 points per 5°C difference). The minimum predicted score was at 25°C (2·6 points [95% CI 2·5-2·7]). Scores increased at temperatures above 25°C to 3·5 points (3·0-4·1) at 35°C and 5·6 points (4·5-6·8) at 40°C. Results were similar for feels like temperature. Interpretation: Raynaud's phenomenon severity is worst at very cold temperatures but also increases with very warm temperatures, presumably due to air conditioning. Clinical management and Raynaud's phenomenon intervention trial designs should consider temperature patterns. Funding: Scleroderma Society of Ontario, Scleroderma Canada, Sclérodermie Québec, Scleroderma Manitoba, Scleroderma Atlantic, Scleroderma Association of BC, Scleroderma SASK, Scleroderma Australia, Scleroderma New South Wales, Scleroderma Victoria, the Canadian Institutes of Health Research, the Arthritis Society, the Lady Davis Institute for Medical Research of the Jewish General Hospital, the Jewish General Hospital Foundation, and McGill University.

Migration patterns of avian embryonic bone marrow cells and their differentiation to functional T and B cells.

Mechanisms of Raynaud's disease

Cold Hands or Feet: Is It Raynaud's or Not?

Kaposiform Hemangioendothelioma Presented with Raynaud Phenomenon: a Case Report

Raynaud's phenomenon associated with psoriatic arthritis

Efficacy analysis of minimally invasive surgery for Raynaud's syndrome

Psychological factors in symptom severity and quality of life in Raynaud's phenomenon

Etiology and Clinical Characteristics of Primary Epistaxis.

Calcium channel blockers for primary Raynaud's phenomenon

Black Tongue: A Rare Presentation of Rhupus Syndrome

An inexpensive and effective device to manage nasal Raynaud’s and rosacea overlap symptoms

Endoscopic thoracic sympathectomy for Raynaud Syndrome

The clinical relevance of Raynaud’s phenomenon symptom characteristics in systemic sclerosis

Scleroderma of the esophagus.

[Experience in Treatment of Raynaud's Syndrome by Chemical Thoracic Sympathectomy].

Mottled Raynaud's phenomenon and hand-arm vibration syndrome: followed up for 10 years

Experience in Treatment of Raynaud's Syndrome by Chemical Sympathectomy:97 Cases

Botulinum Toxin for the Treatment of Raynaud's Conditions of the Hand: Clinical Practice Updates and Future Directions

Capillaroscopic differences between primary Raynaud phenomenon and healthy controls indicate potential microangiopathic involvement in benign vasospasms

Common tongue conditions in primary care

The association of outdoor temperature and self-reported Raynaud's phenomenon severity among people with systemic sclerosis: a Scleroderma Patient-centered Intervention Network Cohort study